Health-related quality of life (HRQoL) assessment with once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial

por Spinosa-Guzman, S, Van de Casteele, T, De La Rosa, G, De Doncker, P
Publicado 2010

Influence of demographic and disease parameters on virological response to once- vs twice-daily darunavir/ritonavir (DRV/r) at week 48 in ODIN

por Sension, M, Arns Da Cunha, C, Domingo, P, Supparatpinyo, K, Van De Casteele, T, De Doncker, P, Tomaka, F
Publicado 2010

No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India

por Handa, S., Villasis-Keever, A., Shenoy, M., Anandan, S., Bhrushundi, M., Garodia, N., Fife, D., De Doncker, P., Shalayda, K., Hu, P., Fonseca, S., Cure-bolt, N.
Publicado 2023